Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients
Top Cited Papers
- 19 April 2021
- journal article
- letter
- Published by Elsevier BV in Kidney International
- Vol. 99 (6), 1496-1498
- https://doi.org/10.1016/j.kint.2021.04.006
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis ProviderAmerican Journal of Kidney Diseases, 2021
- Systematic Review of Safety and Efficacy of COVID-19 Vaccines in Patients With Kidney DiseaseKidney International Reports, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2020
- COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaborationNephrology Dialysis Transplantation, 2020
- A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralizationInfection, 2020
- Outcomes of patients with end-stage kidney disease hospitalized with COVID-19Kidney International, 2020
- Understanding the possible origin and genotyping of the first Bangladeshi SARS‐CoV‐2 strainJournal of Medical Virology, 2020
- Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney TransplantationAmerican Journal of Kidney Diseases, 2020
- Vaccination in Chronic Kidney DiseaseAdvances in Chronic Kidney Disease, 2019